Ultrasonic particles: An approach for targeted gene delivery.
Adv Drug Deliv Rev
; 179: 113998, 2021 12.
Article
in English
| MEDLINE | ID: covidwho-1465980
ABSTRACT
Gene therapy has been widely investigated for the treatment of genetic, acquired, and infectious diseases. Pioneering work utilized viral vectors; however, these are suspected of causing serious adverse events, resulting in the termination of several clinical trials. Non-viral vectors, such as lipid nanoparticles, have attracted significant interest, mainly due to their successful use in vaccines in the current COVID-19 pandemic. Although they allow safe delivery, they come with the disadvantage of off-target delivery. The application of ultrasound to ultrasound-sensitive particles allows for a direct, site-specific transfer of genetic materials into the organ/site of interest. This process, termed ultrasound-targeted gene delivery (UTGD), also increases cell membrane permeability and enhances gene uptake. This review focuses on the advances in ultrasound and the development of ultrasonic particles for UTGD across a range of diseases. Furthermore, we discuss the limitations and future perspectives of UTGD.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Ultrasonics
/
Genetic Therapy
/
Gene Transfer Techniques
/
Molecular Targeted Therapy
Type of study:
Prognostic study
Topics:
Vaccines
Limits:
Animals
/
Humans
Language:
English
Journal:
Adv Drug Deliv Rev
Journal subject:
Pharmacology
/
Drug Therapy
Year:
2021
Document Type:
Article
Affiliation country:
J.addr.2021.113998
Similar
MEDLINE
...
LILACS
LIS